|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-9-8
|
|
pubmed:abstractText |
To investigate the influence of a functional polymorphism of the dopamine D3 receptor (DRD3), and assess its interaction with a Mn superoxide dismutase (MnSOD) polymorphism, in contributing to tardive dyskinesia in a chronic inpatient population with schizophrenia.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0955-8829
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
187-92
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12960753-Age of Onset,
pubmed-meshheading:12960753-China,
pubmed-meshheading:12960753-Dyskinesia, Drug-Induced,
pubmed-meshheading:12960753-Gene Frequency,
pubmed-meshheading:12960753-Genetic Predisposition to Disease,
pubmed-meshheading:12960753-Heterozygote Detection,
pubmed-meshheading:12960753-Humans,
pubmed-meshheading:12960753-Male,
pubmed-meshheading:12960753-Middle Aged,
pubmed-meshheading:12960753-Polymorphism, Genetic,
pubmed-meshheading:12960753-Receptors, Dopamine D2,
pubmed-meshheading:12960753-Receptors, Dopamine D3,
pubmed-meshheading:12960753-Reproducibility of Results,
pubmed-meshheading:12960753-Schizophrenia,
pubmed-meshheading:12960753-Superoxide Dismutase
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia.
|
|
pubmed:affiliation |
Department of Psychiatry, Nanjing Brain Hospital and Nanjing Medical University, Nanjing, People's Republic of China.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
